International Severe Acute Respiratory and Emerging Infection Consortium

Recent papers from International Severe Acute Respiratory and Emerging Infection Consortium

1. Measles resurgence in Bangladesh: a preventable crisis in a transitioning immunisation systemThe Lancet Regional Health - Southeast Asia · 2026
2. Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’The Lancet Regional Health - Southeast Asia · 2025
3. Mpox: The alarm went off. Have we gone back to sleep?PLoS neglected tropical diseases · 2024
4. Long-Term Efficacy of Insecticidal Wall Painting for Controlling Visceral Leishmaniasis Vectors in BangladeshAmerican Journal of Tropical Medicine and Hygiene · 2023
5. Impact of Point-of-Care Rapid Diagnostic Tests on Antibiotic Prescription Among Patients Aged <18 Years in Primary Healthcare Settings in 2 Peri-Urban Districts in Ghana: Randomized Controlled Trial ResultsClinical Infectious Diseases · 2023
6. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health NeedsVaccines · 2023
7. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2023
8. Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelinesBMC Medicine · 2022
9. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparityBMJ Paediatrics Open · 2022
10. Availability, scope, and quality of monkeypox clinical management guidelines globally: a systematic review2022
11. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC–WHO clinical characterisation protocolPLoS Medicine · 2022
12. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohort2022
13. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial2021
14. Development and validation of the 4C Deterioration model for adults hospitalised with COVID-192020
15. Robust, reproducible clinical patterns in hospitalised patients with COVID-192020
16. Early clinical characteristics of Covid-19: scoping review2020
17. Baseline results of a living systematic review for COVID-19 clinical trial registrationsWellcome Open Research · 2020
18. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialTrials · 2020
19. Noninvasive ventilation in critically ill patients with the Middle East respiratory syndromeInfluenza and Other Respiratory Viruses · 2019
20. Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease EpidemicClinical Infectious Diseases · 2017